Abiopharma

U.S. Medicine Magazine Spotlights CyPath® Lung as Promising Tool to Improve Lung Cancer Detection in Veterans, Lower Costs to the VA

Cidara Therapeutics to Present Clinical Phase 2b Data and Preclinical H5N1 Data on CD388 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting

CervoMed to Participate in Upcoming Investor Conferences

LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer

NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025

Cocrystal Pharma to Participate at the H.C. Wainwright Global Investment Conference

MIMEDX to Sponsor and Attend Symposium on Advanced Wound Care (SAWC) Fall

LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer

New real-world data elevating patient perspectives highlight the need for scientific advancement in maternal fetal immunology at ISUOG 2025

Alcon Completes Acquisition of LumiThera

New Form 8-K - enGene Holdings Inc. Filed: 2025-09-03 AccNo: 0000950170-25-112674 Size: 1 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

ZyVersa Therapeutics Highlights Lipidomic Data in Alport Syndrome and DKD Reinforcing the Need for Drugs to Attenuate Damaging Renal Lipid Accumulation to Mitigate Disease Progression

Phio Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

New Form 8-K - Wave Life Sciences Ltd. Filed: 2025-09-03 AccNo: 0001193125-25-194511 Size: 181 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form 8-K - Kiniksa Pharmaceuticals International, plc Filed: 2025-09-03 AccNo: 0001104659-25-086689 Size: 8 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits